ACADIA Pharmaceuticals, Inc. to Present at the 2007 UBS Warburg Global Life Sciences Conference

SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (Nasdaq:ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that it will present at the 2007 UBS Global Life Sciences Conference on Wednesday, September 26, 2007, at 2:00 p.m. Eastern Time at the Grand Hyatt New York Hotel in New York City.